Talis Biomedical Corp - TLIS

Sector: Technology · Industry: Laboratory Analytical Instruments
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2024 · Q1 2024
Value (USD)
Total reported value ($000)
$5.009M
QoQ value delta ($000)
-$70K (-1.38%)
Implied price effect (QoQ)
-0.99%
Shares
Total shares
578,486
QoQ shares delta
-2,292 (-0.39%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (TLIS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2024)

Top 25 only Full list
Early Q3 2024 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
BAKER BROS. ADVISORS LP 4,402 508,323 0.06%
VANGUARD GROUP INC 268 31,013 0.0%
GEODE CAPITAL MANAGEMENT, LLC 123 14,020 0.0%
RENAISSANCE TECHNOLOGIES LLC 106 12,299 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 102 11,607 0.0%
Tower Research Capital LLC (TRC) 7 877 0.0%
Steward Partners Investment Advisory, LLC 1 147 0.0%
JPMORGAN CHASE & CO 0 3 0.0%
BANK OF AMERICA CORP /DE/ 0 13 0.0%
MORGAN STANLEY 0 87 0.0%
UBS Group AG 0 11 0.0%
OSAIC HOLDINGS, INC. 0 84 0.0%
Qube Research & Technologies Ltd 0 2 0.0%